Incyte
INCY
#1110
Rank
HK$156.62 B
Marketcap
HK$797.79
Share price
2.05%
Change (1 day)
36.84%
Change (1 year)

Earnings for Incyte (INCY)

Earnings in 2025 (TTM): HK$12.39 Billion

According to Incyte's latest financial reports the company's current earnings are HK$4.81 Billion. In 2024 the company made an earning of HK$2.46 Billion a decrease over its 2023 earnings that were of HK$6.49 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Incyte from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$12.39 B402.9%
2024 HK$2.46 B-62.04%
2023 HK$6.49 B57.66%
2022 HK$4.11 B-7.24%
2021 HK$4.43 B-345.65%
2020 -HK$1.81 Billion-147.7%
2019 HK$3.78 B322.02%
2018 HK$0.89 B-136.94%
2017 -HK$2.44 Billion-390.76%
2016 HK$0.83 B1322%
2015 HK$58.77 M-115.56%
2014 -HK$0.38 Billion-41.4%
2013 -HK$0.65 Billion87.67%
2012 -HK$0.35 Billion-74.9%
2011 -HK$1.37 Billion843.59%
2010 -HK$0.15 Billion-88.68%
2009 -HK$1.29 Billion1.37%
2008 -HK$1.27 Billion86.16%
2007 -HK$0.68 Billion17.64%
2006 -HK$0.58 Billion-28.62%
2005 -HK$0.81 Billion-36.1%
2004 -HK$1.27 Billion-2.03%
2003 -HK$1.3 Billion22.26%
2002 -HK$1.06 Billion-27.39%
2001 -HK$1.46 Billion198.72%
2000 -HK$0.49 Billion132.2%
1999 -HK$0.21 Billion-556.86%
1998 HK$45.91 M-37.23%
1997 HK$73.14 M-259.32%
1996 -HK$45.92 Million-45.87%
1995 -HK$84.83 Million-9.17%
1994 -HK$93.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
HK$64.15 B 419.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$0.51 B-95.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$175.11 B 1,316.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$92.22 B 646.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-HK$0.36 Billion-102.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-HK$0.44 Billion-103.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$127.76 B 933.79%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
-HK$0.23 Billion-101.83%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-HK$0.54 Billion-104.36%๐Ÿ‡บ๐Ÿ‡ธ USA